SIGI
Loading Today
Sigi is scanning the market and building your Today view.
Live Surface
← Back to StockReal-time stock surface for MBRX.
Visit Moleculin Biotech IncVisit Moleculin Biotech IncUpgrade to Pro Trading WorkspaceLive Day ChartPrice
$9.27
0.00 (0.00%)
Target
$10.32
Conviction
60%
Model-ranked confidence
Upside
+11.3%
Target vs current price
Entry range
$8.80 – $9.10
Preferred accumulation zone
Stop loss
$8.27
Risk management level
Tier
Unrated
Current internal rating
In-Place Chart
MBRX Live Day Chart
Intraday chart stays inside the stock detail page so you can keep signal context, target levels, and execution guidance in view.
Detail Page Embedded
Upgrade to Pro Trading WorkspaceQuick ActionsOpen workspace, watchlist, and portfolio actions.Actions
Quick Actions
Open workspace, watchlist, and portfolio actions.
Smart Chart Access
Unlock Live Candle Chart
Smart and Pro members can view live candle movement, intraday trend, volume behavior, support and resistance zones, and Sigi chart context for MBRX.
Live Chart Locked
Upgrade to Smart to unlock live candle charts and make the Stock Detail page a true market intelligence view.
Upgrade to SmartCancel subscription anytime.
Live intraday movement
Trend and support zones
Sigi chart context
SigiOS master score
Unified technical, fundamental, and conviction score
55
Constructive
Technical
55
Fundamental
52
Conviction
60
Technical intelligence
Real history-based trend, RSI, ATR, and market structure
Technical score
55
TrendNeutral
MomentumBalanced
VolatilityHigh
Support / ResistanceRange
20D SMA
$7.96
50D SMA
$11.04
ATR %
11.18%
RSI 14
52.5
Support 20D
$4.42
Resistance 20D
$11.00
Price
$9.27
Structure
Range
Sigi Elite
Conditional trade plan
Wait for alignment
Wait for directional price structure before defining risk.
Sigi is reading MBRX's Pulse...
Sigi Pro Research
Smart Money - MBRX
Sigi Pro unlocks analyst, institutional, and AMSA research comparisons. Explore Pro
Live FutureMap(TM)
Powered by AMSA
Reading MBRX's market state...
Sigi is combining live price, trend, context, evolution, risk, and scenario probability.
Sigi Investment Thesis
Moleculin Biotech Inc is currently up 49.68%. Volume is running above normal, which makes the move more meaningful. Valuation data is limited, so price action and fundamentals should be weighed carefully. The key read is whether buyers can defend support and push back toward recent highs.
Catalysts
- • Unusual volume activity detected
- • Strong upside momentum
Risk factors
No immediate risk signals.
Core Fundamentals
Key valuation, liquidity, and operating metrics traders check first.
Upgrade to Smart to unlock SIGI metric context
Signal summary
TickerMBRX
CompanyMoleculin Biotech Inc
SectorBiotechnology
ExchangeNASDAQ NMS - GLOBAL MARKET
CountryUS
IPO2016-06-02
Back to search
SigiOS
Unrated-tier company leader with strong AI infrastructure demand.
Latest conviction: 60%
Fundamental intelligence
Valuation, growth, balance sheet, and liquidity read
Fundamental score
63